Search

A transdermal drug delivery system (TDDS) is a method that provides drug adsorption via the skin. TDDS could replace conventional oral administration and blood administration because it is easily accessible. However, it is still difficult to design efficient TDDS due to the high barrier property of skin covered with stratum corneum, which inhibits the permeation of drug molecules. Thus far, TDDS methods by applying physical stimuli such as microneedles and chemical stimuli such as surfactants have been actively developed. However, it has been hard to avoid inflammation at the administration site because these methods partially destroy the skin tissue. On the other hand, TDDS with nanocarriers minimizing damage to the skin tissues has emerged together with the development of nanotechnology in recent years. This review focuses on current trends in TDDS.

In this work, resveratrol was dispersed with anionic phospholipids of 1,2-dipalmitoyl- sn- glycero- 3-phosphorylglycerol (DPPG), 1, 2-dipalmitoyl- sn- glycero- 3-phosphatidic acid, and 1,2-distearoyl- sn-glycero- 3-phosphoglycerol. Moreover, small-sized nanoparticles of kaempferol and indometacin were successfully prepared by using DPPG as a dispersion agent. [ABSTRACT FROM AUTHOR]

In this work, fullerene was dispersed with anionic phospholipids of 1,2-dipalmitoyl-sn-glycero-3-phosphorylglycerol (DPPG) and small-sized fullerene nanoparticles were successfully prepared. [ABSTRACT FROM AUTHOR]